Trade Mark Journal No.2026/010 6 March 2026
WO0000001889892 (5,42)
Office of origin: United States of America
Date of International Registration:11 September 2025
Date of designation in the UK:
11 September 2025

International priority date claimed: 17 March 2025
(United States of America)
(99088465)
- Class 5
- Pharmaceuticals; pharmaceutical preparations, namely, pharmaceutical preparations intended to treat prevalent diseases in humans, namely, cardiometabolic diseases, cardiovascular diseases, hypertension, and obesity.
- Class 42
- Scientific research; scientific research in the fields of pharmaceuticals and medicine; chemical and medical laboratories.
Corsera LLC
Representative: David A. Cole Cadwalader, Wickersham & Taft LLP, 200 Liberty Street, New York NY 10281, UNITED STATES OF AMERICA